Filing Details
- Accession Number:
- 0001209191-15-079188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-09 20:20:23
- Reporting Period:
- 2015-11-09
- Filing Date:
- 2015-11-09
- Accepted Time:
- 2015-11-09 20:20:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504983 | E. Robert Gagnon | C/O Harvard Bioscience, Inc. 84 October Hill Road Holliston MA 01746 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-09 | 3,000 | $3.08 | 66,221 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes (a) a deferred stock award of 26,500 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019; (b) a deferred stock award of 28,117 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 11,604 shares of common stock held by the Reporting Person.
Billionaire Hedge Funds
